Slater Technology Fund Year in Review
2024 was an exciting year for entrepreneurship in Rhode Island. Slater and…
Lenoss Oversubscribes $4 Million Series A Financing
Funding will accelerate commercialization, expand clinical evidence, and fuel…
Slater Invests in Octagon Therapeutics Seed Round
Octagon is developing new medicines for autoimmune disease based on selective…
Bolden Announces $1.5M Pre-Seed Financing
Development of Antisense Oligonucleotides Seeks to Promote Neurogenesis…
MindImmune Appoints Industry Leaders to Board
Brad Margus and Robert Michael Poole, MD FACP, bring deep background and…
Slater to oversee $12M for Rhode Island venture development
By: Jacquelyn Voghel Published in Providence Business News Rhode Island's…
Rhode Island Commerce Awards Slater $12M for Venture Development
VC Firm Receives SSBCI Funding for Second Time Providence, R.I. – In…
Brown-launched biotech secures $375,000 in Slater funding
XM Therapeutics seeks to develop new treatments for chronic heart and pulmonary…
Slater Invests in XM Therapeutics from Brown University
Biotech Targeting Heart Failure and Pulmonary Fibrosis Comes out of Stealth…